Navigation Links
Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia
Date:12/3/2010

a from Study 200 and the ability of the Company to meet anticipated regulatory submission dates; decisions by regulatory authorities regarding whether and when to approve any drug applications that may be filed for any such indications as well as their decisions regarding labeling and other matters that could affect their availability or commercial potential; and competitive developments.

A further description of risks and uncertainties can be found in Pfizer's Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.

(1) ASH Accepted Abstract #208. An Ongoing Phase 3 Study of Bosutinib (SKI-606) Versus Imatinib In Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia. Oral Presentation. Carlo Gambacorti- Presenter. 52nd American Society of Hematology Annual Meeting. Orlando, FL. December 4-7, 2010

(2) ASH Accepted Abstract #892. Bosutinib as Third-Line Treatment for Chronic Phase Chronic Myeloid Leukemia Following Failure of Second-Line Therapy with Dasatinib or Nilotinib. Oral Presentation.  H. J. Khoury - Presenter. 52nd American Society of Hematology Annual Meeting. Orlando, FL. December 4-7, 2010.

(3) GLEEVEC. Prescribing Information. Novartis. East Hanover, NJ. 2010.

(4) SPRYCEL Prescribing Information. Bristol-Myers Squibb. Princeton, NJ. 2010.

(5) TASIGNA Prescribing Information. Novartis. East Hanover, NJ. 2007.

(6) Konig H et al. Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic Cells. Cancer Research. 2008; 68: 9624-9633.

(7) National Cancer Institute. What you need to know about leukemia – Types of Leukemia. Available here: http://www.cancer.gov/cancertopics/wyntk/leukemia/page3. Accessed  November 16, 2010.

(8) Jabbour E et al.
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC)
2. Pfizer Launches New Advil® Congestion Relief and Offers 100 Holiday Shoppers Literal Decongestion From Black Friday Crowds
3. Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
4. Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
5. Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
6. Pfizer Declares an 18-Cent Fourth-Quarter 2010 Dividend
7. Pfizers Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
8. Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.
9. Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil
10. Biocon and Pfizer Enter Into Global Commercialization Agreement
11. Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... MARLBOROUGH, Mass. , Aug. 30, 2014 /PRNewswire/ ... from its NEural Cardiac TherApy foR Heart Failure ... sham-controlled clinical trial investigating vagus nerve stimulation (VNS) ... Zannad, M.D., Ph.D., Professor of Therapeutics and Cardiology ... the Institut National de la Sante et de ...
(Date:8/30/2014)...   Royal Philips  (NYSE: PHG, AEX: PHIA) today ... ultrasound system designed to enable global hospitals and health ... and cost pressures. Making its debut at the  European ... Barcelona this week, Affiniti provides innovative technology ... resources deliver high quality patient care. ...
(Date:8/29/2014)... -- Market Research Report on Global and Chinese ... and in-depth market survey on Global and ... firstly reviews the basic information of X-Ray Crystallography ... The report then explores global and China,s top ... specification, capacity, Production value, and market share etc. ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
... 8, 2011 K-V Pharmaceutical Company (NYSE: KV.A/ KV.B) (the ... ® , the only U.S. Food & Drug Administration ("FDA") ... in women with singleton pregnancy who have a history of ... was launched during March of 2011. From its launch date ...
... 8, 2011 Thompson MIS is pleased to announce ... "Best New Technology for Spine Care in 2011" award ... the company during the annual meeting of the North ... is a patented system that enables surgeons to more ...
Cached Medicine Technology:K-V Pharmaceutical Announces Updated Makena® Performance Metrics 2K-V Pharmaceutical Announces Updated Makena® Performance Metrics 3K-V Pharmaceutical Announces Updated Makena® Performance Metrics 4K-V Pharmaceutical Announces Updated Makena® Performance Metrics 5K-V Pharmaceutical Announces Updated Makena® Performance Metrics 6K-V Pharmaceutical Announces Updated Makena® Performance Metrics 7K-V Pharmaceutical Announces Updated Makena® Performance Metrics 8
(Date:8/30/2014)... Pittsburgh, PA (PRWEB) August 30, 2014 ... the result of a car accident," said one of ... constant muscle strain in her shoulder and neck area. ... we invented reduced pain and pressure, assisting in comfort ... for the patent-pending PILLOW CRADLE to support the head, ...
(Date:8/30/2014)... Texas (PRWEB) August 30, 2014 ... Oven Industry, 2009-2019 is a professional and in-depth ... industry. The report firstly reviews the basic information ... manufacturing technology. The report then explores global and ... product specification, capacity, production value, and market share ...
(Date:8/30/2014)... Serving contented clients since inception, #1 web ... is now offering discount for Labor Day on ... on putting forward the best of web development technology ... team of professionals and web developers and designers has ... the critical issues of web development and can develop ...
(Date:8/30/2014)... York, New York (PRWEB) August 30, 2014 ... litigation for transvaginal mesh lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) ... company’s request to sever four cases selected for ... an Order issued on August 18, 2014, U.S. ... District of West Virginia disagrees with Boston Scientific’s ...
(Date:8/30/2014)... 2014: Transvenous lead extraction (TLE) is clinically successful in ... the European Lead Extraction ConTRolled (ELECTRa) registry presented for ... Dr Maria Grazia Bongiorni, chair of the registry,s executive ... implantable electronic devices (CIED) implant procedures has grown in ... complications has increased and leads are often the cause. ...
Breaking Medicine News(10 mins):Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a leading provider ... disease,announced today that it plans to report its financial results ... of market on July 29., VNUS plans to host ... ET on July 29. This call will be webcast live ...
... 14 In response to last week,s,widely reported story ... government for services prescribed by dead physicians,Patrick O,Connell of ... the Texas,Attorney General,s Civil Medicaid Fraud Section, has called ... in the prosecution,of such cases., "This is a ...
... Pennsylvania, 90 percent of Medicaid LTC funds for ... 14 A new report by AARP,s,Public Policy ... state,government efforts to balance long-term care (LTC) options ... states spent more than 50,percent of their Medicaid ...
... Successful and Timely Program ... Implementation, ... selection by the Centers for Medicare & Medicaid Services,(CMS) of the ... 325 medical equipment suppliers nationwide to serve Medicare,beneficiaries under its Competitive ...
... 14 Preliminary findings,from a landmark independent, ... released today at the Project Management Institute,s ... organizational,performance can be significantly improved through the ... the Value of Project Management," is,"unequivocal in ...
... Billups of the Detroit Pistons, DETROIT, July 14 ... Annual Celebrity Golf Classic is just around the,corner on ... The day is sure to be fun and ... shotgun start at 11:00 a.m. Highlights of the,event include ...
Cached Medicine News:Health News:VNUS Medical Technologies to Report Second-Quarter 2008 Results and Webcast Teleconference on July 29 2Health News:Government Ill-Equipped to Prevent Medicaid Fraud, Says False Claims Act Expert 2Health News:New AARP Report Finds Older Americans Have Limited Access to Home and Community-Based Services Under Medicaid 2Health News:All-Med Services of Florida Awarded Medicare Competitive Bidding Contract 2Health News:Study: Global Business Performance Significantly Improved Through Project Management 2Health News:Come Tee-Up at The Children's Center 24th Annual Celebrity Golf Classic! 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: